)

Inotiv (NOTV) investor relations material
Inotiv H.C. Wainwright 27th Annual Global Investment Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Business Overview and Growth
Expanded from $20M to $500M in seven years, focusing on preclinical contract research and integrating research models and services.
Operates in a $25B addressable market, with two main segments: research models (RMS) and discovery and safety assessment (DSA).
DSA business is a key growth driver, with 25-27% year-over-year award growth in recent quarters and a Q3 2025 book-to-bill ratio of 1.07x with a $134.3M backlog.
RMS margins improved through site optimization, cost reduction, and a shift to a recurring business model.
Innovation and the emergence of new biotech firms continue to expand the client base, with small and midsized biopharma companies increasing their share of R&D spend.
Strategic Initiatives and Operational Improvements
Transitioned from acquisition-driven growth to integration and optimization, consolidating facilities and modernizing operations to boost efficiency and revenue per site.
Integrated services and rebranding have positioned the company as a full-service provider for small and mid-sized pharma clients.
Developed enterprise study management and IT systems, reducing IT systems by 34% and improving operational visibility and client experience.
Enhanced compliance and animal welfare standards, with a new Chief Compliance Officer, comprehensive compliance plan, and exemplary AAALAC ratings.
Insourced North American transportation, optimizing routes, reducing costs, and improving delivery reliability and animal welfare.
Financial Performance and Outlook
Q3 2025 revenue reached $130.7M, up 23.5% year-over-year, with RMS contributing 63% and DSA 37%.
Long-term goals include $590–$610M in revenue and 16.5%–18.5% adjusted EBITDA margin, with a clear path based on current run rates and infrastructure.
Site optimization is expected to yield $6M–$7M in annual cost savings, with completion targeted by Q2 fiscal 2026.
Pricing improvements expected as discounting declines and quality/on-time delivery improves.
Legal settlement proceeds are being used to fund capital expenditures.
Next Inotiv earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage